Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

Inclusion Criteria * Male or female, smoker or non-smoker, 18 years of age and older. * BMI greater than or equal to 19.0 and less than or equal to 30.0 kg/m2 Exclusion Criteria Subjects to whom any of the following applies will be excluded from the study: * Clinically significant illnesses or surgery within 4 weeks of the administration of study medication. * Any clinically significant abnormality or abnormal laboratory test results found during medical screening. * Any reason which, in the opinion of the medical subinvestigator, would prevent the subject from participating in the study. * Positive testing for hepatitis B, hepatitis C or HIV at screening. * ECG abnormalities (clinically significant) or vital sign abnormalities (systolic blood pressure lower than 90 or over 140 mmHg, or diastolic blood pressure lower than 50 or over 90mmHg; or heart rate less than 50 or over 100 bpm) at screening. * History of significant alcohol abuse or drug abuse within one year prior to the screening visit. * Regular use of alcohol within six months prior to the screening visit (more than 14 units of alcohol per \[1 Unit = 150 mL of wine or 360 mL of beer or 45 mL of 40% alcohol\], or positive alcohol breath test at screening. * Use of soft drugs (such as marijuana) within 3 months of the screening visit or hard drugs (such as cocaine, phencyclidine (PCP) and crack) within 1 year prior to the screening visit or positive urine drug screen at screening. * History of allergic reactions t…